Microbot Medical (MBOT) regains NASDAQ compliance

Microbot Medical (NASDAQ: MBOT) a Delaware-based company specializing in surgical and medical instruments, announced today that it has regained compliance with Nasdaq's minimum bid price requirement. The company received a notification from Nasdaq Stock Market LLC confirming that the minimum closing bid price for Microbot Medical's common stock remained at or above $1.00 per share for 15 consecutive business days, from December 26, 2024, to January 17, 2025.

You May Also Be Interested In

• Goldman Sachs (GS) Reiterated at Market Perform by Citizens on Constructive Backdrop
• Hertz prices share lending deal tied to new debt offering
• Nano Nuclear CEO takes interim reactor development role after CTO departs